Novo Nordisk | DŁUG



Debt Zmiana Data
ANI Pharmaceuticals USD 621.56M 1.26M 2025-06
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.74B 228M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 6.6M 6.6M 2025-06
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 39.9B 1.39B 2025-06
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.27B 12M 2025-03
Novo Nordisk 118.72B 61.75B 2025-03
Novo Nordisk DKK 118.72B 61.75B 2025-03
Pacira USD 580.49M 2.88M 2025-06
Perrigo USD 3.65B 24.4M 2025-06
Prestige Brands USD 1.04B 27.25M 2025-06
Sanofi 22.28B 1.24B 2025-06
Supernus Pharmaceuticals USD 31.77M 531K 2025-06
Zoetis USD 6.79B 214M 2025-06


Novo Nordisk DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.